Literature DB >> 24067876

Levofloxacin-induced hepatotoxicity and death.

Muge Gulen1, Mehmet Oguzhan Ay, Akkan Avci, Ayca Acikalin, Ferhat Icme.   

Abstract

Drug-induced hepatotoxicity is a major cause of hepatocellular injury in patients admitting to emergency services with acute liver failure. Hepatic necrosis may be at varying degrees from mild elevations in transaminases to fulminant hepatitis, and even death. The case of a 53-year-old female patient with toxic hepatitis due to levofloxacin and multiple organ failure secondary to toxic hepatitis is presented. Patient suffered itching, redness, and rash after receiving a single dose of 750 mg of levofloxacin tablets for pulmonary infection 10 days ago. Skin lesions had regressed within 3 days, but desquamation formed all over the body. After the fifth day of drug intake, complaints of abdominal pain, vomiting, and yellowing in skin color had started. The patient was referred to our emergency department with these complaints 10 days after drug intake. Patient was thought as a candidate for liver transplant, but cardiopulmonary arrest occurred, and the patient died before she could be referred to a transplant center. This case is important because hepatotoxicity and death due to levofloxacin is uncommon in the literature.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24067876     DOI: 10.1097/MJT.0b013e3182a44055

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  7 in total

1.  A Case of Levofloxacin-Induced Hepatotoxicity.

Authors:  Michael Schloss; Daniel Becak; Sebastian T Tosto; Arash Velayati
Journal:  Am J Case Rep       Date:  2018-03-10

2.  Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study.

Authors:  Hong-Yi Yang; Dai-Hong Guo; Wang-Ping Jia; Man Zhu; Yuan-Jie Xu; Xiao-Yu Wang
Journal:  Ther Clin Risk Manag       Date:  2019-03-08       Impact factor: 2.423

3.  Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2022-03-15       Impact factor: 3.064

4.  The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling.

Authors:  Sreenivasa C Ramaiahgari; Scott S Auerbach; Trey O Saddler; Julie R Rice; Paul E Dunlap; Nisha S Sipes; Michael J DeVito; Ruchir R Shah; Pierre R Bushel; Bruce A Merrick; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

5.  What Is Uncommon Can Be Critical: A Case of Quinolone-Induced Acute Liver Failure.

Authors:  Bibek Bakhati; Victoria M Sibi; Armugam P Mekala; Joshua A Ronen; Sai Mungara
Journal:  Cureus       Date:  2021-04-30

6.  Systemic quinolones and risk of acute liver failure III: A nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  J Gastroenterol Hepatol       Date:  2021-03-31       Impact factor: 4.029

7.  Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system.

Authors:  Mohamed Kadry Taher; Abdallah Alami; Christopher A Gravel; Derek Tsui; Lise M Bjerre; Franco Momoli; Donald R Mattison; Daniel Krewski
Journal:  JGH Open       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.